Jason X. Cheng to Prostatic Neoplasms
This is a "connection" page, showing publications Jason X. Cheng has written about Prostatic Neoplasms.
Connection Strength
0.485
-
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy. Oncotarget. 2016 Jul 12; 7(28):44224-44235.
Score: 0.246
-
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma. Chronobiol Int. 2016; 33(2):210-9.
Score: 0.239